Naoko Nagatani

Retinoblastoma Inactivation Induces a Protumoral Microenvironment via Enhanced CCL2 Secretion

Fengkai Li, Shunsuke Kitajima, Susumu Kohno et al. · Cancer Research · 2019 · 91 citations

Medicine, Cancer Biology, Oncology +17

Treatment of Retinoblastoma 1–Intact Hepatocellular Carcinoma With Cyclin‐Dependent Kinase 4/6 Inhibitor Combination Therapy

Jindan Sheng, Susumu Kohno, Nobuhiro Okada et al. · Hepatology · 2021 · 38 citations

Medicine, Oncology, Pharmacology +17

Undifferentiated State Induced by Rb-p53 Double Inactivation in Mouse Thyroid Neuroendocrine Cells and Embryonic Fibroblasts

Shunsuke Kitajima, Susumu Kohno, Atsushi Kondo et al. · Stem Cells · 2015 · 23 citations · Full text

Medicine, Genetics, Oncology +17

Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion

Susumu Kohno, Paing Linn, Naoko Nagatani et al. · Oncogene · 2020 · 18 citations

Medicine, Oncology, Pharmacology +10

<i>MicroRNA-140</i> mediates RB tumor suppressor function to control stem cell-like activity through interleukin-6

Akiyo Yoshida, Shunsuke Kitajima, Fengkai Li et al. · Oncotarget · 2017 · 14 citations · Full text

Life Sciences, Cell Biology, Oncology +17